
AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B
2026/1/16 | 2 mins.
Milestone brings hope to patients with rare inherited retinal disease

SpliceBio Begins Dose-Expansion Phase of Clinical Trial for Stargardt Disease Protein Splicing Therapy
2026/1/13 | 3 mins.
First patient treated in Part B of ASTRA trial evaluating SB-007.

Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg
2026/1/09 | 47 mins.
Josh Steinberg and his father, Jon, talk with host Ben Shaberman about their close-knit family's journey with Josh's vision loss and eventual diagnosis of retinitis pigmentosa, as well as their volunteer leadership roles in driving the Foundation's mission. Jon is Chair of the Foundation's Science Committee and Vice Chair for Science on the Board. Josh is the former Chair of the Strategic Council and also a Board director.

Eye on the Cure Podcast | Episode 97: Lindsey Rambo
2025/12/19 | 39 mins.
Lindsey Rambo, a special education teaching assistant, mom, and wife, talks to host Ben Shaberman about her journey with Leber congenital amaurosis 5 (LCA5), participation in Opus Genetics' LCA5 gene therapy clinical trial, and her appearance on Good Morning America to tell her story about meaningful vision improvements.

Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy
2025/12/18 | 2 mins.
The company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.



Foundation Fighting Blindness